Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for Treatment and Prophylaxis of COVID-19
NCT04668469Completed
- Sponsor
- Benha University
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by Benha University. Started Jun 2020; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04668469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04668469.